MBX Biosciences, Inc. MBX Ratios & Valuation
| FY'25 | FY'24 | ||
|---|---|---|---|
| Returns | |||
| Return on equity | -27.8%— | —— | |
| Return on assets | -26.6%+8.5pp | -35.1%— | |
| Return on invested capital | -39%— | —— | |
| Liquidity | |||
| Current ratio | 24.6×+0.4× | 24.2×+2.9× | |
| Quick ratio | 24.6×+0.4× | 24.2×+2.9× | |
| Cash ratio | 4.9×+0.4× | 4.5×-3.3× | |
| Leverage | |||
| Debt-to-equity | 0×0.0× | 0×— | |
| Debt-to-assets | 0×0.0× | 0×0.0× | |
| Per Share | |||
| Book value per share | $10.11-58.2% | $24.19+134% | |
| Valuation | |||
| Market capitalization | $1.42B+130% | $615.88M— | |
| Enterprise value | $1.34B+137% | $566.7M— | |
| Price / book | 3.8×+1.4× | 2.4×— | |
| Free cash flow yield | -5.8%+3.2pp | -9%— | |
| Earnings yield | -6.1%+3.9pp | -10.1%— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do MBX Biosciences, Inc.'s ratios come from?
- Every ratio is computed from MBX Biosciences, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.